CanSeq150

CanSeq150 program will lay the foundation for Canada’s next 150 years of science.

Purpose
To commemorate the 150th Birthday of Canada in 2017 and to lay the foundation of Canadian excellence in research for the next 150 years, Canada’s Genomics Enterprise (CGEn) and its partners are embarking upon the Canada 150 Sequencing Initiative (CanSeq150). The aim is to sequence 150 new genomes to support sequence-based genomics research in Canada by enabling future research in biodiversity and conservation, applications in breeding and biomedicine, as well as technology development, across Canada.

The genomes to be sequenced will be chosen by allowing the research community to nominate and present a case for their species of choice, in a rapid peer-reviewed, competitive process. The results of the competitive review will be made public after the completion of the selection process, along with some genomes proposed by CGEn scientists and collaborators. The genome sequences generated will be made available to researchers worldwide through the most relevant databases including the newly announced Canadian Genomic Cloud resource.

In this era of genome sequencing, ultimately, as many of Earth’s species and individuals as possible, should be sequenced. The CanSeq150 Initiative is designed to play its part as CGEn’s contribution towards achieving this common global goal, while enhancing and showcasing Canada’s capabilities in genomic science.

Deliverables
For each sample, CGEn will perform DNA quality analysis, whole genome sequencing (WGS) up to 30X depth using 10X Genomics and/or Illumina X technologies, or WGS data generated by using PacBio or other sequencing technologies and also basic genome assembly.

Partnership
Canseq150 will not be possible without the investment of time and resource by all of our partners.

Process
To apply for a species of choice to be sequenced, free of cost to the applicant, interested applicants must complete this form and submit directly to CGEn using the email address provided below. Application will be considered on a first-come-first-reviewed basis until the goal of sequencing 150 species is achieved.

Please email CanSeq150@cgen.ca for application forms and further information.

The CanSeq150 evaluation committee, consisting of individuals with a wide range of relevant expertise, will review the submitted applications on a rolling basis. The committee will evaluate the applications for their relevance to the overall goal of the CanSeq150 program. Decisions will be communicated directly to the applicant within 4 weeks after an application is received.

Depending on the level of interaction required to complete the project, CGEn support may only be required to complete the genome sequencing, to conduct all aspects of sequencing and informatics/analysis, or to have an intermediate role of support. CGEn’s primary motivation is to provide the best scientific study design for the genome being considered, and to deliver a high-quality genome sequence to the community.

Terms & Conditions 

Information sharing
Information regarding the species accepted for sequencing will be posted on the CGEn website and communicated via social media. Exceptions will be possible in rare situations, for example where there is significant international competition, at the request of the applicant and approval of the evaluation committee.

Data release and sharing
CGEn recognizes publication as a vehicle for data release and, at a minimum, expects all data to be released and shared no later than the original publication date of the main findings from any datasets generated by this program or one year after the date the data was generated, whichever comes first. This requirement is not meant to be contrary to any data release requirements of the publishing journal or other agencies funding different aspects of the work. All sequencing data generated by CGEn will be publicly available via CGEn’s website or another public data repository after the release date.

Access to publication
CGEn requires that all peer reviewed publications that have been supported, in whole or in part, by CGEn’s CanSeq150 program be made freely accessible online in a central or institutional repository as soon as possible, and, at the latest, six months after the publication date. Publication costs will be covered by the lead author of the study.

Acknowledgment and/or authorship
All publications must acknowledge CanSeq150 in the following or similar manner: “Funding for sequencing was supported through the CanSeq150 program of Canada’s Genomics Enterprise (www.cgen.ca)”. When appropriate, contributions of CGEn researchers may warrant co-authorship on scientific publications, following the International Committee of Medical Journal Editors guidelines.